Literature DB >> 30385889

Synthesis of Enantiomerically Pure Anti-Aldols: A Highly Stereoselective Ester-Derived Titanium Enolate Aldol Reaction.

Arun K Ghosh1, Masanobu Onishi1.   

Abstract

Entities:  

Year:  1996        PMID: 30385889      PMCID: PMC6207085          DOI: 10.1021/ja9539148

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


× No keyword cloud information.
  1 in total

1.  Highly Enantioselective Aldol Reaction: Development of a New Chiral Auxiliary from cis-1-Amino-2-hydroxyindan.

Authors:  Arun K Ghosh; Tien T Duong; Sean P McKee
Journal:  J Chem Soc Chem Commun       Date:  1992
  1 in total
  5 in total

1.  A Stereoselective Anti-Aldol Route to (3R,3aS,6aR)-Hexahydrofuro[2,3-b] furan-3-ol: A Key Ligand for a New Generation of HIV Protease Inhibitors.

Authors:  Arun K Ghosh; Jianfeng Li; Ramu Sridhar Perali
Journal:  Synthesis (Stuttg)       Date:  2006-09       Impact factor: 3.157

2.  Chelation-controlled ester-derived titanium enolate aldol reaction: diastereoselective syn-aldols with mono- and bidentate aldehydes.

Authors:  Arun K Ghosh; Jae-Hun Kim
Journal:  Tetrahedron Lett       Date:  2002-07-17       Impact factor: 2.415

3.  Synthesis of Bioactive Natural Products by Asymmetric syn- and anti-Aldol Reactions.

Authors:  Arun K Ghosh; Zachary L Dawson
Journal:  Synthesis (Stuttg)       Date:  2009-09       Impact factor: 3.157

4.  Highly Stereoselective Asymmetric Aldol Routes to tert-Butyl-2-(3,5-difluorophenyl)-1-oxiran-2-yl)ethyl)carbamates: Building Blocks for Novel Protease Inhibitors.

Authors:  Arun K Ghosh; Emilio L Cárdenas; Margherita Brindisi
Journal:  Tetrahedron Lett       Date:  2017-09-14       Impact factor: 2.415

5.  Allenoate Prenucleophiles: A Triply Diastereoselective Approach to β-Hydroxy Esters Containing All-Carbon α-Quaternary Centers.

Authors:  Samantha L Maki; Pradip Maity; Shannon Dougherty; Jennifer Johns; Salvatore D Lepore
Journal:  Org Lett       Date:  2019-09-16       Impact factor: 6.072

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.